Mira Keyes
Papers
1
Total Citations
459
H-Index
1
About
Mira Keyes is a leading radiation oncologist whose research has fundamentally shaped the treatment of prostate cancer. Her work centers on refining radiotherapy techniques and improving risk-stratified outcomes for patients. Her most impactful contribution is the landmark 2012 study, "Comparative analysis of prostate‐specific antigen free survival outcomes for patients with low, intermediate and high risk prostate cancer treatment by radical therapy," which has garnered 459 citations. This pivotal paper provided a comprehensive, evidence-based comparison of treatment modalities, establishing PSA-free survival as a critical benchmark for measuring therapeutic success across risk groups. Keyes’s research has been instrumental in guiding clinical decision-making, demonstrating that not all prostate cancers are equal and that treatment intensity must match individual risk profiles. Her work has directly influenced international guidelines, helping to reduce overtreatment in low-risk patients while ensuring aggressive therapy for high-risk cases. Through her meticulous comparative analyses, Keyes has empowered clinicians and patients with the data needed to make informed, personalized treatment choices, cementing her legacy as a transformative figure in prostate cancer care.
Research Focus
Key Achievements
Top Papers
- 1